-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2021 to 2023.
- Amylyx Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $76.1M, a 9.4% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $469M, a 55.2% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $342M, a 53% increase from 2022.
- Amylyx Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $224M, a 169% increase from 2021.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)